Diabetes Clinical Trials in Washington

Showing 81-100 of 334 trials

Enhance Study: Evaluation of Accuracy and Safety of the Eversense CGM System With Enhanced Features

NCT05131139

A Prospective, Multicenter Evaluation of Accuracy and Safety of the Eversense CGM System with Enhanced Features. The purpose of this clinical investigation is to evaluate the accuracy of the Eversense 524 Continuous Glucose Monitoring System (Eversense 524 CGM System) and ROME CGM System with next generation feature enhancements compared to reference glucose measurements in adults 18 years of age and older with diabetes. The investigation will also evaluate safety of the Eversense 524 CGM System and ROME CGM System usage. Additionally, the safety and accuracy of the Eversense 524 CGM System will be evaluated in the pediatric population ages 14-17 with Type 1 Diabetes Mellitus.

Diabetes MellitusDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2

Senseonics, Inc.350 participantsStarted Oct 2021

Escondido, California, United States • Idaho Falls, Idaho, United States • San Antonio, Texas, United States +1 more locations

COMPLETED34 miles

User Performance of the TV4 BGMS

NCT05647824

Thunder V4 (TV4) is the code name of a blood glucose monitoring system (BGMS) consisting of a new meter and new Contour FIT test strips. This clinical trial will assess the performance (accuracy) of the TV4 meter by lay users enrolled as subjects in the study, and by health care professionals (also called study staff).

Diabetes Mellitus

Ascensia Diabetes Care402 participantsStarted Feb 2020

Walnut Creek, California, United States • Idaho Falls, Idaho, United States • Renton, Washington, United States

COMPLETEDPhase 234 miles

A Phase 2 Study of LY3209590 in Participants With Type 2 Diabetes Mellitus

NCT04450394

The reason for this study is to see if the study drug LY3209590 is safe and effective in participants with type 2 diabetes.

Type 2 Diabetes Mellitus

Eli Lilly and Company278 participantsStarted Jul 2020

Sheffield, Alabama, United States • Huntington Park, California, United States • Los Angeles, California, United States +61 more locations

Enhance Study: Evaluation of Accuracy and Safety of the Eversense CGM System With Enhanced Features

User Performance of the TV4 BGMS

A Phase 2 Study of LY3209590 in Participants With Type 2 Diabetes Mellitus

Diabetes Trials in Other Cities

CGMIS 48-hour Feasibility Study

Comparison of SAR341402 to NovoLog/NovoRapid in Adult Patients With Diabetes Mellitus Also Using Insulin Glargine

Non-inferiority Study to Compare the Efficacy and Safety of Mylan's Insulin Glargine With Lantus® in Type 1 Diabetes Mellitus Patients (INSTRIDE 1)

Mylan Insulin Aspart Study

Nxstan: A Culturally Tailored Intervention to Prevent Diabetes in American Indian Men

A Study to Assess the Safety and Tolerability of Different Doses of AG019 Administered Alone or in Combination With Teplizumab in Participants With Recent-onset Diagnosed Type 1 Diabetes (T1D)

A Study of Dulaglutide (LY2189265) in Children and Adolescents With Type 2 Diabetes

Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Children and Adolescents With Type 1 Diabetes Mellitus

Alveolar Bone Changes in Diabetes (ABCD) Study

Non-inferiority Study to Compare the Efficacy and Safety of Mylan's Insulin Glargine With Lantus® in Type 2 Diabetes Mellitus Patients (INSTRIDE 2)

A Research Study to Compare Two Doses of Semaglutide Taken Once Weekly in People With Type 2 Diabetes

A Study to Test Whether Different Doses of BI 456906 Are Effective in Treating Adults With Type 2 Diabetes.

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes Mellitus on Basal Plus Mealtime Insulin

Effect of Sotagliflozin on Cardiovascular Events in Participants With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial)

An Extension Trial of Inclisiran in Participants With Cardiovascular Disease and High Cholesterol

Study Comparing the Efficacy and Safety of Insulin Glargine (Basal Insulin)/Lixisenatide (GLP-1 Receptor Agonist) Combination (Soliqua™) in Patients With Type 2 Diabetes Mellitus (T2DM)

Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes Mellitus Treated With Diet and Exercise Only

Other Conditions in Washington